ÂÜÀòÂÒÂ×

David Oxley brings extensive commercial experience in life sciences, with a focus in novel technologies in the biotech and life sciences sectors. He has a proven track record of commercial success, including prosecuting complex, cross-border licensing constructs, inclusive of non-dilutive capital raising, world-wide commercial P&L management, and new product launch experience.

Within the biotech sector, his most recent experience includes service as senior vice president of business development and licensing for Melbourne-based, cellular medicines leader, Mesoblast, where he continues his service as a consultant.